Evidence map›Paper›PMID 35171366›Full record

ArticleClinical rheumatology2022

Retrospective study of 98 patients with X-linked agammaglobulinemia complicated with arthritis.

Ran Qing-Qi, Li Ya-Wen, Chen Huan, Zhang Yu, An Yun-Fei, Tang Xue-Mei, Zhao Xiao-Dong, Zhang Zhi-Yong

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ran Qing-QiDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
Li Ya-WenDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
Chen HuanDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
Zhang YuDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
An Yun-FeiDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
Tang Xue-MeiDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China.
Zhao Xiao-DongNational Clinical Research Center for Child Health and Disorders, Chongqing, 40015, China.
Zhang Zhi-YongDepartment of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, 400015, China. zzy510214@216.com.ORCID http://orcid.org/0000-0001-9130-9916
China International Science and Technology Cooperation · CNChildren's Hospital of Chongqing Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe preformed this retrospective study of clinical manifestation, imaging feature, and mutations to describe joint involvement in X-linked agammaglobulinemia (XLA) patients, aimed to provide recommendation for physicians.

methodsA total number of 98 XLA patients who have been diagnosed between January 2000 and February 2020 were enrolled and grouped based on whether they developed arthritis and analyzed for the clinical, imaging, and gene mutation data using the t test or the Mann-Whitney test.

resultsForty-five out of 98 patients (45.9%) had joint involvement, 40.8% had symptom prior to the diagnosis of XLA, and 54.1% had no articular symptom. Patients with joint involvement had a higher median diagnostic age of XLA and initial IgG level than patients without it, while their intravenous immunoglobulin was lower (p < 0.05). Knee, hip, and ankle were the most frequent joint, and oligoarthritis (≦ 4 joints) was more common than polyarthritis (88.9% vs 11.1%). Red and tenderness were the most frequent clinical symptoms (80%) with 24.4% reporting limited activity and 8.9% reporting deformity. Imaging data collected from 32 patients indicated that joint effusion (53.3%), synovitis (15.5%), and swollen soft tissue (15.5%) were the most common feature. Seventeen patients were treated by antibiotics plus intravenous immunoglobulin (IVIG) with an effective rate of 70.6%, and 28 patients only received IVIG with an effective rate of 67.9%. In comparison to patients without arthritis who have higher frequency nonsense and frameshift mutation, patients with arthritis had a higher incidence of missense mutation (p < 0.05).

conclusionHigh prevalence of arthritis among X-linked agammaglobulinemia patients and subsequent progression through IVIG replacement therapy highlight the importance of timely diagnosis and better management of these patients. Our finding indicated a potential correlation between genotype and phenotype, and further research on the mechanism of arthritis in XLA patients could increase physicians' awareness and improve patients' prognosis. Key Points • This study described the feature of arthritis in XLA patients and indicated a potential correlation between this complication and genotype.

Indexed as

AgammaglobulinemiaArthritisGenetic Diseases, X-LinkedHumansImmunoglobulins, IntravenousMutationRetrospective StudiesImmunoglobulins, IntravenousArthritisGene mutationIntravenous immunoglobulinX-linked agammaglobulinemia

Identifiers

PMID35171366
OpenAlexW4212992206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.